Russia begins mass trials of second coronavirus vaccine
Russia plans to begin mass trials of its second coronavirus vaccine, EpiVacCorona, on people aged over 18 on Monday, the RIA news agency has cited the consumer health watchdog Rospotrebnadzor as saying.
EpiVacCorona, which is being developed by Siberia's Vector Institute, was authorized this month to carry out trials on 150 volunteers over 60 and 3,000 volunteers over 18, the watchdog has said.
The trials will be conducted in Moscow and several other cities, including Kazan and Kaliningrad, the TASS news agency cited it as saying.
Coronavirus cases have surged in Russia since September, but authorities have resisted imposing a touch lockdown and have said that targeted measures are enough to cope with the crisis.
Russia said earlier this month that its other Sputnik V vaccine was 92% effective at protecting people from COVID-19 according to interim results.
Authorities confirmed 26,338 new coronavirus cases on Monday, including 6,511 in Moscow and 3,691 in St Petersburg, taking the national total to 2,295,654 since the pandemic began.
They also reported 368 deaths in the last 24 hours, pushing the official death toll to 39,895.
(Source: Reuters)
Russia launches 'ICBM' for first time against Ukraine: Kiev
Russia lowers nuclear weapons threshold after US allows Ukraine to use missiles
Russia says Biden 'fueling' tensions by permitting Ukraine missile strikes
Iran to launch ‘new, advanced’ centrifuges in response to IAEA resolution: AEOI
Yemen fires hypersonic missile at Israeli airbase
VIDEO | New Delhi chokes under toxic smog as air quality remains at hazardous levels
VIDEO | Press TV's news headlines
VIDEO | ICC's arrest warrant for Netanyahu to worry Western politicians: Former British diplomat
Iranians protest against Israel after Netanyahu ICC warrant
Germany undecided on complying with ICC arrest warrants for Israeli war criminals
VIDEO | Former FBI agent criticizes US Congress for 'outright corruption'
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
